leadf
logo-loader
viewRedx Pharma PLC

Redx Pharma’s majority shareholder Redmile ups stake to 91.76% of the company

The hedge fund made a counter-offer in March after Yesod Bio-Sciences’ proposed to take over for 15p per share

Redx Pharma PLC - Redx Pharma’s majority shareholder Redmile ups stake to 91.76% of the company

Redx Pharma PLC’s (LON:REDX) majority shareholder Redmile has increased its stake to 91.76% from 58.25%.

The hedge fund offered on 13 March to acquire the entire issued capital for 15.5p per share, with shareholders representing 33.51% of the pharma company agreeing to sell.

It was a counter-offer to Yesod Bio-Sciences’ proposal to take over for 15p per share, after the stock closed on 12 March at 4.5p.

Quick facts: Redx Pharma PLC

Price: 57.5 GBX

AIM:REDX
Market: AIM
Market Cap: £112.27 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Redx Pharma PLC named herein, including the promotion by the Company of Redx Pharma PLC in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Fireweed Zinc identifies new target at boundary zone as company adds to...

Fireweed Zinc (CVE: FWZ) CEO Brandon Macdonald joined Steve Darling from Proactive Vancouver with news the company has discovered at a new target west of Boundary Zone. That was discovered at a new gravity target located 360 m west of prior Boundary Zone drilling. Macdonald also told Proactiv...

1 hour, 41 minutes ago

2 min read